Delivery Order SPE2DB20D2002-SPE2DB25FL19W

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,336.83 with a completion date of March 21, 2024. The award was issued by the Defense Logistics Agency (DLA) and covers the supply of Trelegy Ellipta 200-62.5-25 60S, a specialty medication. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,642.40 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,191.62 delivery order is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. This contract is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. The contract award, with a ceiling value of $3,162.90 and a completion date of January 10, 2023, is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract is a firm fixed-price delivery order, with no set-aside designation. As a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,730.61 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,998.80 Firm Fixed Price Delivery Order contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $1,210.08 issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, to support federal healthcare programs. This delivery order has a completion date of March 25, 2024 and is a firm fixed-price contract. The contract does not have a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,365.02 firm-fixed-price contract is for the purchase of TRELEGY ELLIPTA 100-62.5-25 60S medication. The award has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,859.60 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The award, valued at $1,431.08, is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract does not have a set-aside designation, indicating open competition. As a major pharmaceutical distributor and healthcare solutions...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB25FL19W
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,070.66 for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 13, 2025.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The contract award reviewed is not designated with any set-aside requirements, indicating open competition.

Generated 5/14/25, 10:09 AM